Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03360903 · ClinicalTrials.gov registry record · Phase 4

A Study to Determine if Caffeine Accelerates Emergence From Propofol Anesthesia

A Phase 4 study, sponsored by University of Chicago.

Completed
Registry status
Phase 4
Development phase
8
Enrollment target

NCT03360903 is a Phase 4 study that has completed, run by University of Chicago. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03360903, a Phase 4 study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
Phase 4
Development phase
8 participants
Enrollment target

Study Summary

At present clinicians have no way to reverse anesthesia. Patients wake when their bodies clear the anesthetic. Most people wake quickly, but some do not. All patients have memory and other cognitive problems after waking from anesthesia. In studies on animals, the investigators observed that caffeine caused rats to wake much more rapidly from propofol anesthesia. This was true for all the animals tested. The investigators would like to see if this holds true in humans. Will caffeine accelerate waking from anesthesia? Will it reverse the cognitive deficits associated with anesthesia, after waking? The propose investigators carrying out a modest trial with 8 test subjects. Each volunteer will be anesthetized twice. Each volunteer will be anesthetized one time and receive an infusion of saline (placebo control), without the aid of any other drugs and the other time the volunteer will receive an infusion of a relatively low dose of caffeine. The order of saline versus caffeine will be randomized and the study will be done in a double blind manner. We will determine whether emergence from propofol anesthesia will be significantly accelerated by the caffeine infusion. And whether any adverse events are observed.

Interventions

  • DRUG Placebo
  • DRUG Caffeine

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2018-01-02
Est. Completion 2019-06-01
Phase Phase 4

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT03360903

The ClinicalTrials.gov registry entry for NCT03360903 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT03360903 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03360903 about?

NCT03360903 is a clinical study titled "A Study to Determine if Caffeine Accelerates Emergence From Propofol Anesthesia". At present clinicians have no way to reverse anesthesia. Patients wake when their bodies clear the anesthetic. Most people wake quickly, but some do not. All patients have memory and other cognitive problems after waking from anesthesia. In studies on animals, the investigators observed that caffein...

What is the current status of trial NCT03360903?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2018-01-02. Estimated completion is 2019-06-01.

What interventions are being tested in trial NCT03360903?

The interventions under investigation include: Placebo (DRUG), Caffeine (DRUG).

Who is sponsoring clinical trial NCT03360903?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.